Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab in combination with chemotherapy for newly diagnosed HIV-associated Burkitt lymphoma has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-02-28